Complications following Breast Augmentation using Injectable Fillers in Kuwait

The study aims to evaluate and present clinical outcomes and complications associated with breast augmentation using injectable fillers and autologous fat transfer.

This is a retrospective case series of patients who presented with complications following breast augmentation via injectable fillers or autologous fat grafting between September 2015 and November 2019 at a private clinic in Kuwait.

Amongst the 10 patients, 8 had complications from injectable fillers; co-polyamide (n=4), hyaluronic acid (n=1), collagen (n=1), unknown materials (n=3) and 2 from autologous fat transfer. Common complications included mastalgia (90%), palpable masses (80%), cyst formation (80%), filler migration (30%), and infection (20%). Imaging revealed multiple cystic lesions, filler deposition, and inflammatory changes, with several cases categorized as Breast Imaging Reporting and Data System-4 (BIRADS-4), which required biopsy. Surgical interventions, including mastectomy and drainage, were required in 40% of cases, while others were managed conservatively with imaging follow-up and/or aspiration.

Injectable fillers for breast augmentation, particularly unregulated substances, are associated with a high risk of serious complications requiring invasive management. This study emphasizes the need for strict regulation, increased public awareness, and reliance on FDA-approved methods such as silicone implants or autologous fat grafting.